Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Sales (2020 - 2025)

Journey Medical's Return on Sales history spans 6 years, with the latest figure at 0.08% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 21.0% year-over-year to 0.08%, compared with a TTM value of 0.19% through Dec 2025, up 8.0%, and an annual FY2025 reading of 0.19%, up 8.0% over the prior year.
  • Return on Sales for Q4 2025 was 0.08% at Journey Medical, up from 0.14% in the prior quarter.
  • The five-year high for Return on Sales was 1.1% in Q3 2023, with the low at 1.24% in Q4 2021.
  • Average Return on Sales over 5 years is 0.33%, with a median of 0.28% recorded in 2025.
  • Year-over-year, Return on Sales plummeted -142bps in 2021 and then skyrocketed 172bps in 2023.
  • Tracing DERM's Return on Sales over 5 years: stood at 1.24% in 2021, then skyrocketed by 36bps to 0.8% in 2022, then skyrocketed by 82bps to 0.14% in 2023, then surged by 189bps to 0.13% in 2024, then plummeted by -164bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for DERM's Return on Sales are 0.08% (Q4 2025), 0.14% (Q3 2025), and 0.25% (Q2 2025).